5 News & Press Releases found
Iktos News
-
Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design and Sygnature Discovery, a leading integrated drug discovery CRO headquartered in Nottingham, UK, with expertise across a range of therapeutic and biological target ...
-
Iktos and Teijin Pharma to Co-Develop New Technology for Small Molecule Drug Discovery
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design, and Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business that provides comprehensive healthcare services to improve the ...
-
Iktos Announces a Collaboration With Ono in Artificial Intelligence for New Drug Design
Iktos, a company specialized in Artificial Intelligence (AI) for new drug design today announced a collaboration agreement with Ono Pharmaceuticals Co., Ltd., a leading pharmaceutical company based in Japan with a focus on innovative medicines ...
-
Makya Webinar 2021
Topic: Makya: AI-driven de novo drug design and multi-parametric optimisation Recording Duration: 56:50 Webinar Start Time: Dec 7, 2021, 10 - 11 AM CET & 5 - 6 PM CET Access to the Recorded Webinar
-
Spaya Webinar: 2021
Webinar on Spaya: AI-Enhanced Retrosynthesis for Chemists ...